Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

• Main Authors: Martina Penazzato, Claire L. Townsend, Natella Rakhmanina, Yao Cheng, Moherndran Archary, Tim R. Cressey, Maria H. Kim, Victor Musiime, Anna Turkova, Theodore D. Ruel, Helena Rabie, Nandita Sugandhi, Pablo Rojo, Meg Doherty, Elaine J. Abrams, Elaine Abrams, Jintanat Ananworanich, Isabelle Andrieux-Meyer, Yodit Belew, Brookie Best, Rosa Bologna, Jessica Burry, Deborah Carpenter, Polly Clayden, Angela Colbers, Magda Conway, Timothy R. Cressey, Mutsa Dangarembizi, Shaffiq Essajee, Maribel Gonzalez Tome, Andrew Hill, Saye Khoo, Maria Kim, Linda Lewis, Janice Lee, Shahin Lockman, Imelda Mahaka, Mark H. Mirochnick, Lynne Mofenson, Mireille Muhimpundu, Angela Mushavi, Elizabeth Obimbo, Fernando Pascual, Carmen Perez Casas, Anton Pozniak, Theodore Ruel, Jonathan Schapiro, George Siberry, Teresa Beatriz Simione, Cheick Tidiane Tall, Francois Venter, Marissa Vicari, Jenny Walsh, Jacque Wambui, Melynda Watkins
• Format: Journal
• Published: 2019
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85071639026&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/66680
• Institution: Chiang Mai University

© 2019 Elsevier Ltd Despite considerable progress in paediatric HIV treatment and timely revision of global policies recommending the use of more effective and tolerable antiretroviral regimens, optimal antiretroviral formulations for infants, children, and adolescents remain limited. The Paediatric...